Global Parenteral PrEP Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Parenteral PrEP Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Parenteral PrEP Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Cabotegravir
  • 1.2.3 Lenacapavir
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Parenteral PrEP Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Subcutaneous Use
  • 1.3.3 Intramuscular Use
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Parenteral PrEP Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Parenteral PrEP Revenue by Region
  • 2.2.1 Global Parenteral PrEP Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Parenteral PrEP Revenue by Region (2019-2024)
  • 2.2.3 Global Parenteral PrEP Revenue by Region (2025-2030)
  • 2.2.4 Global Parenteral PrEP Revenue Market Share by Region (2019-2030)
• 2.3 Global Parenteral PrEP Sales Estimates and Forecasts 2019-2030
• 2.4 Global Parenteral PrEP Sales by Region
  • 2.4.1 Global Parenteral PrEP Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Parenteral PrEP Sales by Region (2019-2024)
  • 2.4.3 Global Parenteral PrEP Sales by Region (2025-2030)
  • 2.4.4 Global Parenteral PrEP Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Parenteral PrEP Sales by Manufacturers
  • 3.1.1 Global Parenteral PrEP Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Parenteral PrEP Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Parenteral PrEP in 2023
• 3.2 Global Parenteral PrEP Revenue by Manufacturers
  • 3.2.1 Global Parenteral PrEP Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Parenteral PrEP Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Parenteral PrEP Revenue in 2023
• 3.3 Global Key Players of Parenteral PrEP, Industry Ranking, 2021 VS 2022
• 3.4 Global Parenteral PrEP Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Parenteral PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Parenteral PrEP, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Parenteral PrEP, Product Offered and Application
• 3.8 Global Key Manufacturers of Parenteral PrEP, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Parenteral PrEP Sales by Type
  • 4.1.1 Global Parenteral PrEP Historical Sales by Type (2019-2024)
  • 4.1.2 Global Parenteral PrEP Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Parenteral PrEP Sales Market Share by Type (2019-2030)
• 4.2 Global Parenteral PrEP Revenue by Type
  • 4.2.1 Global Parenteral PrEP Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Parenteral PrEP Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Parenteral PrEP Revenue Market Share by Type (2019-2030)
• 4.3 Global Parenteral PrEP Price by Type
  • 4.3.1 Global Parenteral PrEP Price by Type (2019-2024)
  • 4.3.2 Global Parenteral PrEP Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Parenteral PrEP Sales by Application
  • 5.1.1 Global Parenteral PrEP Historical Sales by Application (2019-2024)
  • 5.1.2 Global Parenteral PrEP Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Parenteral PrEP Sales Market Share by Application (2019-2030)
• 5.2 Global Parenteral PrEP Revenue by Application
  • 5.2.1 Global Parenteral PrEP Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Parenteral PrEP Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Parenteral PrEP Revenue Market Share by Application (2019-2030)
• 5.3 Global Parenteral PrEP Price by Application
  • 5.3.1 Global Parenteral PrEP Price by Application (2019-2024)
  • 5.3.2 Global Parenteral PrEP Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Parenteral PrEP Market Size by Type
  • 6.1.1 US & Canada Parenteral PrEP Sales by Type (2019-2030)
  • 6.1.2 US & Canada Parenteral PrEP Revenue by Type (2019-2030)
• 6.2 US & Canada Parenteral PrEP Market Size by Application
  • 6.2.1 US & Canada Parenteral PrEP Sales by Application (2019-2030)
  • 6.2.2 US & Canada Parenteral PrEP Revenue by Application (2019-2030)
• 6.3 US & Canada Parenteral PrEP Market Size by Country
  • 6.3.1 US & Canada Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Parenteral PrEP Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Parenteral PrEP Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Parenteral PrEP Market Size by Type
  • 7.1.1 Europe Parenteral PrEP Sales by Type (2019-2030)
  • 7.1.2 Europe Parenteral PrEP Revenue by Type (2019-2030)
• 7.2 Europe Parenteral PrEP Market Size by Application
  • 7.2.1 Europe Parenteral PrEP Sales by Application (2019-2030)
  • 7.2.2 Europe Parenteral PrEP Revenue by Application (2019-2030)
• 7.3 Europe Parenteral PrEP Market Size by Country
  • 7.3.1 Europe Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Parenteral PrEP Revenue by Country (2019-2030)
  • 7.3.3 Europe Parenteral PrEP Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Parenteral PrEP Market Size by Type
  • 8.1.1 China Parenteral PrEP Sales by Type (2019-2030)
  • 8.1.2 China Parenteral PrEP Revenue by Type (2019-2030)
• 8.2 China Parenteral PrEP Market Size by Application
  • 8.2.1 China Parenteral PrEP Sales by Application (2019-2030)
  • 8.2.2 China Parenteral PrEP Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Parenteral PrEP Market Size by Type
  • 9.1.1 Asia Parenteral PrEP Sales by Type (2019-2030)
  • 9.1.2 Asia Parenteral PrEP Revenue by Type (2019-2030)
• 9.2 Asia Parenteral PrEP Market Size by Application
  • 9.2.1 Asia Parenteral PrEP Sales by Application (2019-2030)
  • 9.2.2 Asia Parenteral PrEP Revenue by Application (2019-2030)
• 9.3 Asia Parenteral PrEP Market Size by Region
  • 9.3.1 Asia Parenteral PrEP Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Parenteral PrEP Revenue by Region (2019-2030)
  • 9.3.3 Asia Parenteral PrEP Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Parenteral PrEP Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Parenteral PrEP Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Parenteral PrEP Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Parenteral PrEP Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Parenteral PrEP Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Parenteral PrEP Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Parenteral PrEP Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Parenteral PrEP Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Parenteral PrEP Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Parenteral PrEP Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Gilead Sciences
  • 11.1.1 Gilead Sciences Company Information
  • 11.1.2 Gilead Sciences Overview
  • 11.1.3 Gilead Sciences Parenteral PrEP Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Gilead Sciences Parenteral PrEP Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Gilead Sciences Recent Developments
• 11.2 ViiV Healthcare
  • 11.2.1 ViiV Healthcare Company Information
  • 11.2.2 ViiV Healthcare Overview
  • 11.2.3 ViiV Healthcare Parenteral PrEP Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 ViiV Healthcare Parenteral PrEP Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 ViiV Healthcare Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Parenteral PrEP Industry Chain Analysis
• 12.2 Parenteral PrEP Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Parenteral PrEP Production Mode & Process
• 12.4 Parenteral PrEP Sales and Marketing
  • 12.4.1 Parenteral PrEP Sales Channels
  • 12.4.2 Parenteral PrEP Distributors
• 12.5 Parenteral PrEP Customers

13 Parenteral PrEP Market Dynamics

• 13.1 Parenteral PrEP Industry Trends
• 13.2 Parenteral PrEP Market Drivers
• 13.3 Parenteral PrEP Market Challenges
• 13.4 Parenteral PrEP Market Restraints

14 Key Findings in the Global Parenteral PrEP Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Parenteral PrEP Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Cabotegravir

Table 3. Major Manufacturers of Lenacapavir

Table 4. Major Manufacturers of Other

Table 5. Global Parenteral PrEP Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Parenteral PrEP Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Parenteral PrEP Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Parenteral PrEP Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Parenteral PrEP Revenue Market Share by Region (2019-2024)

Table 10. Global Parenteral PrEP Revenue Market Share by Region (2025-2030)

Table 11. Global Parenteral PrEP Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global Parenteral PrEP Sales by Region (2019-2024) & (K Units)

Table 13. Global Parenteral PrEP Sales by Region (2025-2030) & (K Units)

Table 14. Global Parenteral PrEP Sales Market Share by Region (2019-2024)

Table 15. Global Parenteral PrEP Sales Market Share by Region (2025-2030)

Table 16. Global Parenteral PrEP Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Parenteral PrEP Sales Share by Manufacturers (2019-2024)

Table 18. Global Parenteral PrEP Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Parenteral PrEP Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Parenteral PrEP, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Parenteral PrEP Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global Parenteral PrEP Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Parenteral PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral PrEP as of 2023)

Table 24. Global Key Manufacturers of Parenteral PrEP, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Parenteral PrEP, Product Offered and Application

Table 26. Global Key Manufacturers of Parenteral PrEP, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 29. Global Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 30. Global Parenteral PrEP Sales Share by Type (2019-2024)

Table 31. Global Parenteral PrEP Sales Share by Type (2025-2030)

Table 32. Global Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Parenteral PrEP Revenue Share by Type (2019-2024)

Table 35. Global Parenteral PrEP Revenue Share by Type (2025-2030)

Table 36. Parenteral PrEP Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Parenteral PrEP Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 39. Global Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 40. Global Parenteral PrEP Sales Share by Application (2019-2024)

Table 41. Global Parenteral PrEP Sales Share by Application (2025-2030)

Table 42. Global Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Parenteral PrEP Revenue Share by Application (2019-2024)

Table 45. Global Parenteral PrEP Revenue Share by Application (2025-2030)

Table 46. Parenteral PrEP Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Parenteral PrEP Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Parenteral PrEP Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Parenteral PrEP Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Parenteral PrEP Sales by Country (2025-2030) & (K Units)

Table 61. Europe Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 62. Europe Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 63. Europe Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 66. Europe Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 67. Europe Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Parenteral PrEP Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Parenteral PrEP Sales by Country (2019-2024) & (K Units)

Table 73. Europe Parenteral PrEP Sales by Country (2025-2030) & (K Units)

Table 74. China Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 75. China Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 76. China Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 79. China Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 80. China Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 83. Asia Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 84. Asia Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 87. Asia Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 88. Asia Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Parenteral PrEP Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Parenteral PrEP Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Parenteral PrEP Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Parenteral PrEP Sales by Region (2019-2024) & (K Units)

Table 94. Asia Parenteral PrEP Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Parenteral PrEP Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Parenteral PrEP Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Parenteral PrEP Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Parenteral PrEP Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Parenteral PrEP Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Parenteral PrEP Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Parenteral PrEP Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Parenteral PrEP Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Parenteral PrEP Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Parenteral PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Parenteral PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Parenteral PrEP Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Parenteral PrEP Sales by Country (2025-2030) & (K Units)

Table 108. Gilead Sciences Company Information

Table 109. Gilead Sciences Description and Major Businesses

Table 110. Gilead Sciences Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Gilead Sciences Parenteral PrEP Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Gilead Sciences Recent Developments

Table 113. ViiV Healthcare Company Information

Table 114. ViiV Healthcare Description and Major Businesses

Table 115. ViiV Healthcare Parenteral PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. ViiV Healthcare Parenteral PrEP Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. ViiV Healthcare Recent Developments

Table 118. Key Raw Materials Lists

Table 119. Raw Materials Key Suppliers Lists

Table 120. Parenteral PrEP Distributors List

Table 121. Parenteral PrEP Customers List

Table 122. Parenteral PrEP Market Trends

Table 123. Parenteral PrEP Market Drivers

Table 124. Parenteral PrEP Market Challenges

Table 125. Parenteral PrEP Market Restraints

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Parenteral PrEP Product Picture

Figure 2. Global Parenteral PrEP Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Parenteral PrEP Market Share by Type: 2023 & 2030

Figure 4. Cabotegravir Product Picture

Figure 5. Lenacapavir Product Picture

Figure 6. Other Product Picture

Figure 7. Global Parenteral PrEP Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Parenteral PrEP Market Share by Application: 2023 & 2030

Figure 9. Subcutaneous Use

Figure 10. Intramuscular Use

Figure 11. Parenteral PrEP Report Years Considered

Figure 12. Global Parenteral PrEP Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 14. Global Parenteral PrEP Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Parenteral PrEP Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Parenteral PrEP Revenue Market Share by Region (2019-2030)

Figure 17. Global Parenteral PrEP Sales (2019-2030) & (K Units)

Figure 18. Global Parenteral PrEP Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Parenteral PrEP Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Parenteral PrEP Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Parenteral PrEP Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Parenteral PrEP Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Parenteral PrEP Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Parenteral PrEP Sales YoY (2019-2030) & (K Units)

Figure 25. China Parenteral PrEP Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Parenteral PrEP Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Parenteral PrEP Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Parenteral PrEP Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Parenteral PrEP Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Parenteral PrEP Sales Share by Manufacturers (2023)

Figure 31. The Parenteral PrEP Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Parenteral PrEP Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Parenteral PrEP in the World: Market Share by Parenteral PrEP Revenue in 2023

Figure 34. Global Parenteral PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 36. Global Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 37. Global Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 38. Global Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Parenteral PrEP Revenue Share by Country (2019-2030)

Figure 44. US & Canada Parenteral PrEP Sales Share by Country (2019-2030)

Figure 45. US Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 48. Europe Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 49. Europe Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 50. Europe Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 51. Europe Parenteral PrEP Revenue Share by Country (2019-2030)

Figure 52. Europe Parenteral PrEP Sales Share by Country (2019-2030)

Figure 53. Germany Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 54. France Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 58. China Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 59. China Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 60. China Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 61. China Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 62. Asia Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 63. Asia Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 64. Asia Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 65. Asia Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 66. Asia Parenteral PrEP Revenue Share by Region (2019-2030)

Figure 67. Asia Parenteral PrEP Sales Share by Region (2019-2030)

Figure 68. Japan Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 72. India Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Parenteral PrEP Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Parenteral PrEP Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Parenteral PrEP Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Parenteral PrEP Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Parenteral PrEP Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Parenteral PrEP Sales Share by Country (2019-2030)

Figure 80. Brazil Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Parenteral PrEP Revenue (2019-2030) & (US$ Million)

Figure 85. Parenteral PrEP Value Chain

Figure 86. Parenteral PrEP Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed